Veröffentlichungen
Originalarbeiten, Bücher, Buchkapitel und Übersichtsartikel von Prof. Marcus Maurer
Verwendung: Beginnen Sie mit einer Übersicht über alle Publikationen. Verwenden Sie Tag-Links, um markierte Dokumente aufzulisten oder eine ganze Kategorie aufzulisten, z.B. Original Work (Originalarbeiten), Books (Bücher), Book Chapters (Buchkapitel), Reviews (Übersichtsartikel). Wenn Sie wissen, was Sie suchen, dann geben Sie diesen Begriff in das Suchfeld ein.
- Order by:
- Title
- Date added
- Download count
- [o.390] A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency (2)
- [o.263] Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the icatibant outcome survey (0)
- [o.216] Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies (0)
- [o.217] Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies (0)
- [r.128] Disease severity, activity, impact, and control and how to assess them in patients with hereditary angioedema (4)
- [o.302] Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the icatibant outcome survey, a cohort observational study (4)
- [o.359] Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey (0)
- [o.326] Evaluation of avoralstat, an oral kallikrein inhibitor, in a phase 3 hereditary angioedema prophylaxis trial: the OPuS-2 study (0)
- [r.186] Expert consensus on prophylactic treatment of hereditary angioedema (1)
- [r.186de] Expert consensus on prophylactic treatment of hereditary angioedema (0)
- [o.225] F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema (0)
- [o.289] Genetic determinants of C1 inhibitor deficiency angioedema age of onset (0)
- [o.337] Guideline: Hereditary angioedema due to C1 inhibitor deficiency. S1-Guideline of the German Society for Angioedema (DGA), German Society for Internal Medicine (DGIM), German Society for Otorhinolaryngology (DGHNO), German Society for Allergology and Clinical Immunology (DGAKI), German Society for Child and Adolescent Medicine (DGKJ), German Dermatological Society (DDG), German Society for Pediatric Allergology and Environmental Medicine (GPA), German Association of ENT Surgeons (BVHNO) and the German HAE Patient Association (HAE-SHG) (0)
- [o.167] Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe (0)
- [r.122] Hereditary angioedema with normal C1 inhibitor: Update on evaluation and treatment (0)
- [r.045] Hereditary angioedema: an update on available therapeutic options (0)
- [o.205] Hereditary angioedema: Molecular and clinicaldifferences among European populations (0)
- [o.426] Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study (2)
- [o.328] Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the icatibant outcome survey (3)
- [o.404] Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks (2)
(Last update: 12.2023)
Number of original publications in peer-reviewed journals: | 580 |
Number of reviews in peer-reviewed journals: | 210 |
Number of publications (original work and reviews) in peer-reviewed journals: | 790 |
Cumulative IF for original publications in peer-reviewed journals: | 4196.39 |
Cumulative IF for reviews in peer-reviewed journals: | 1409.32 |
Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5605.71 |
Total number of citations: 36,836, h-index: 99 (Web of Science December 2023) | 36836 |
Download-Information
Um die angebotenen Veröffentlichungen herunterladen zu können, müssen Sie sich einloggen. Wenn Sie das Login nicht kennen, schreiben Sie mir bitte Ihre Anfrage.